ALS News Today Forums › Forums › ALS Progress › ALS News › Enrollment Complete for Levosimendan’s REFALS Trial in ALS

  • ALS News

    Enrollment Complete for Levosimendan’s REFALS Trial in ALS

    Posted by ALS News Today Moderator on August 5, 2019 at 6:10 pm

    Orion announced that the REFALS Phase 3 trial has completed its target enrollment to explore the beneficial effects of levosimendan in ALS patients. Read more about it here.

    How do you feel about this news?

    replied 4 years, 9 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .